These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29917035)

  • 1. How can nanotechnology help the fight against breast cancer?
    Avitabile E; Bedognetti D; Ciofani G; Bianco A; Delogu LG
    Nanoscale; 2018 Jul; 10(25):11719-11731. PubMed ID: 29917035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era.
    Neagu AN; Jayaweera T; Weraduwage K; Darie CC
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Advances in Nanotechnology-Based Diagnosis and Therapeutics for Breast Cancer: An Assessment of Active-Targeting Inorganic Nanoplatforms.
    Falagan-Lotsch P; Grzincic EM; Murphy CJ
    Bioconjug Chem; 2017 Jan; 28(1):135-152. PubMed ID: 27973767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnological selection.
    Demming A
    Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
    Chen Y; Wu Y; Sun B; Liu S; Liu H
    Small; 2017 Mar; 13(10):. PubMed ID: 28075057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostics Aspects of Various Nanoparticles in Veterinary Medicine.
    Bai DP; Lin XY; Huang YF; Zhang XF
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
    Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
    ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graphene as cancer theranostic tool: progress and future challenges.
    Orecchioni M; Cabizza R; Bianco A; Delogu LG
    Theranostics; 2015; 5(7):710-23. PubMed ID: 25897336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Two-Dimensional Nanomaterials in Breast Cancer Theranostics.
    Mohammadpour Z; Majidzadeh-A K
    ACS Biomater Sci Eng; 2020 Apr; 6(4):1852-1873. PubMed ID: 33455353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation.
    Singh P; Singh D; Sa P; Mohapatra P; Khuntia A; K Sahoo S
    Nanomedicine (Lond); 2021 Jun; 16(14):1219-1235. PubMed ID: 33998837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon nanomaterials as versatile platforms for theranostic applications.
    Kim M; Jang J; Cha C
    Drug Discov Today; 2017 Sep; 22(9):1430-1437. PubMed ID: 28533188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging cancer cells with nanostructures: Prospects of nanotechnology driven non-invasive cancer diagnosis.
    Augustine R; Mamun AA; Hasan A; Salam SA; Chandrasekaran R; Ahmed R; Thakor AS
    Adv Colloid Interface Sci; 2021 Aug; 294():102457. PubMed ID: 34144344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing Intelligent Nanomaterials to Achieve Highly Sensitive Diagnoses and Multimodality Therapy of Bladder Cancer.
    Li G; Wu S; Chen W; Duan X; Sun X; Li S; Mai Z; Wu W; Zeng G; Liu H; Chen T
    Small Methods; 2023 Feb; 7(2):e2201313. PubMed ID: 36599700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.